Allianz Asset Management’s TG Therapeutics TGTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,100
| Closed | -$280K | – | 1797 |
|
|
2025
Q1 | $280K | Sell |
7,100
-15,100
| -68% | -$595K | ﹤0.01% | 1588 |
|
|
2024
Q4 | $668K | Sell |
22,200
-7,700
| -26% | -$232K | ﹤0.01% | 1340 |
|
|
2024
Q3 | $699K | Buy |
+29,900
| New | +$699K | ﹤0.01% | 1339 |
|
|
2022
Q2 | – | Sell |
-207,025
| Closed | -$1.97M | – | 1884 |
|
|
2022
Q1 | $1.97M | Sell |
207,025
-72,181
| -26% | -$687K | ﹤0.01% | 1373 |
|
|
2021
Q4 | $5.31M | Buy |
279,206
+4,837
| +2% | +$92K | ﹤0.01% | 1100 |
|
|
2021
Q3 | $9.13M | Buy |
274,369
+43,394
| +19% | +$1.44M | 0.01% | 934 |
|
|
2021
Q2 | $8.96M | Buy |
230,975
+94,514
| +69% | +$3.67M | 0.01% | 858 |
|
|
2021
Q1 | $6.58M | Buy |
136,461
+13,040
| +11% | +$628K | 0.01% | 917 |
|
|
2020
Q4 | $6.42M | Sell |
123,421
-27,453
| -18% | -$1.43M | 0.01% | 959 |
|
|
2020
Q3 | $4.04M | Buy |
150,874
+17,417
| +13% | +$466K | ﹤0.01% | 1035 |
|
|
2020
Q2 | $2.6M | Buy |
133,457
+25,621
| +24% | +$499K | ﹤0.01% | 1198 |
|
|
2020
Q1 | $1.06M | Sell |
107,836
-39,055
| -27% | -$384K | ﹤0.01% | 1431 |
|
|
2019
Q4 | $1.63M | Buy |
+146,891
| New | +$1.63M | ﹤0.01% | 1531 |
|
|
2018
Q4 | – | Sell |
-169,628
| Closed | -$950K | – | 2202 |
|
|
2018
Q3 | $950K | Buy |
169,628
+14,316
| +9% | +$80.2K | ﹤0.01% | 1790 |
|
|
2018
Q2 | $2.04M | Sell |
155,312
-899
| -0.6% | -$11.8K | ﹤0.01% | 1517 |
|
|
2018
Q1 | $2.22M | Buy |
156,211
+18,231
| +13% | +$259K | ﹤0.01% | 1468 |
|
|
2017
Q4 | $1.13M | Buy |
137,980
+8,602
| +7% | +$70.5K | ﹤0.01% | 1702 |
|
|
2017
Q3 | $1.53M | Buy |
129,378
+4,530
| +4% | +$53.7K | ﹤0.01% | 1575 |
|
|
2017
Q2 | $1.26M | Buy |
+124,848
| New | +$1.26M | ﹤0.01% | 1614 |
|